Sean Jordan

April 28, 2025

Marina’s Talk Wins Best Oral Presentation Award at AWSOM 2025!

Congrats to Marina Michaud, whose presentation titled “Integrated Coding and Non-Coding Transcriptional Single-Cell Atlas of Multiple Myeloma: Unraveling the Effects of Myeloma Genotype on the Bone Marrow” won the award for best oral presentation at the 2025 Atlanta Workshop on Single-cell Omics! Way to go, Marina – your exemplary performance makes the lab proud! Looking forward to seeing even more great work from you.
April 28, 2025

Denis’s Poster Wins Best Poster Award at AWSOM 2025!

Congrats to Denis Ohlstrom, whose presentation titled “Longitudinal characterization of multiple myeloma and the immune microenvironment” won the award for best poster presentation at the 2025 Atlanta Workshop on Single-cell Omics! Way to go Denis – you’re making the lab proud!
October 9, 2024

DFUCare: deep learning platform for diabetic foot ulcer detection, analysis, and monitoring

INTRODUCTION: Diabetic foot ulcers (DFUs) are a severe complication among diabetic patients, often leading to amputation or even death. Early detection of infection and ischemia is essential for improving healing outcomes, but current diagnostic methods are invasive, time-consuming, and costly. There is a need for non-invasive, efficient, and affordable solutions in diabetic foot care.
September 25, 2024

MERTK inhibition selectively activates a DC – T-cell axis to provide anti-leukemia immunity

TAM-family tyrosine kinases (TYRO3, AXL and MERTK) are potential cancer therapeutic targets. In previous studies MERTK inhibition in the immune microenvironment was therapeutically effective in a B-cell acute leukemia (B-ALL) model. Here, we probed anti-leukemia immune mechanisms and evaluated roles for TYRO3 and AXL in the leukemia microenvironment. Host Mertk knock-out or MERTK inhibitor MRX-2843 increased CD8α^(+) dendritic cells (DCs) with enhanced antigen-presentation capacity in the...